# Travecta Therapeutics Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/travecta-therapeutics-pte

- Industry: Biotechnology
- Headquarters: Singapore, Singapore
- Website: www.travectatx.com
- Total disclosed funding: $27M
- Latest round: Series A (Jul 21, 2020)
- Investors on record: 5

## About

Travecta Therapeutics Pte. Ltd. is a biotechnology company focusing on advanced drug delivery systems to improve the bioavailability and efficacy of therapeutic compounds.Founded in 2017 in Singapore, Travecta Therapeutics Pte. Ltd. develops innovative drug delivery solutions. The company has raised USD 5.25 mn in Series A funding, with its most recent investment round occurring on September 5, 2022. The firm has completed three deals total, which have contributed to its current valuation of USD 67.96 mn.Travecta TX specializes in delivering advanced drug delivery systems aimed at enhancing the bioavailability of therapeutic compounds. Their technology addresses key challenges in the pharmaceutical sector, optimizing the delivery of both small molecules and biologics, and catering to a client base that includes pharmaceutical companies and research institutions focused on developing therapies for oncology, neurology, and metabolic diseases.In 2021, Travecta TX reported a revenue of USD 112,500, while experiencing an EBITDA loss of USD 7,601,780.To support its growth strategy, Travecta Therapeutics plans to utilize the USD 5.25 mn raised in Series A funding for the development of new products and to expand its market presence. The company aims to enhance its drug delivery solutions and enter new geographic markets, specifically targeting regions in North America and Europe by 2023. This growth initiative follows the recent funding round, which will provide the necessary resources to advance their innovative product offerings.

## Funding rounds

- Series A, Jul 21, 2020, $27M — Albrekca, Dominion Fiduciary, Tikehau Capital, Sprim Ventures, Celeste Management

## Investors

- Albrekca — Series A
- Dominion Fiduciary — Series A
- Tikehau Capital — Series A
- Sprim Ventures (https://capitalatlas.ai/funds/sprim-ventures) — Series A
- Celeste Management — Series A